<!DOCTYPE html>
<html lang="en"><head>
<meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1"><!-- Begin Jekyll SEO tag v2.8.0 -->
<title>üíä Lessons for Modern Drug Development from the Golden Age of Antibiotics | Just-in-Time learning</title>
<meta name="generator" content="Jekyll v3.10.0" />
<meta property="og:title" content="üíä Lessons for Modern Drug Development from the Golden Age of Antibiotics" />
<meta property="og:locale" content="en_US" />
<meta name="description" content="Inquisitive. Learning. Sharing. Simplicity = Reliability" />
<meta property="og:description" content="Inquisitive. Learning. Sharing. Simplicity = Reliability" />
<link rel="canonical" href="http://0.0.0.0:4000/golden-age-of-antibiotics/" />
<meta property="og:url" content="http://0.0.0.0:4000/golden-age-of-antibiotics/" />
<meta property="og:site_name" content="Just-in-Time learning" />
<meta property="og:type" content="article" />
<meta property="article:published_time" content="2025-01-07T00:00:00+00:00" />
<meta name="twitter:card" content="summary" />
<meta property="twitter:title" content="üíä Lessons for Modern Drug Development from the Golden Age of Antibiotics" />
<script type="application/ld+json">
{"@context":"https://schema.org","@type":"BlogPosting","dateModified":"2025-01-07T00:00:00+00:00","datePublished":"2025-01-07T00:00:00+00:00","description":"Inquisitive. Learning. Sharing. Simplicity = Reliability","headline":"üíä Lessons for Modern Drug Development from the Golden Age of Antibiotics","mainEntityOfPage":{"@type":"WebPage","@id":"http://0.0.0.0:4000/golden-age-of-antibiotics/"},"url":"http://0.0.0.0:4000/golden-age-of-antibiotics/"}</script>
<!-- End Jekyll SEO tag -->
<link href="https://unpkg.com/@primer/css/dist/primer.css" rel="stylesheet" />
<link rel="stylesheet" href="/assets/main.css"><link type="application/atom+xml" rel="alternate" href="http://0.0.0.0:4000/feed.xml" title="Just-in-Time learning" />
<link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/katex@0.11.1/dist/katex.min.css" integrity="sha384-zB1R0rpPzHqg7Kpt0Aljp8JPLqbXI3bhnPWROx27a9N0Ll6ZP/+DiW/UqRcLbRjq" crossorigin="anonymous">
<script type="text/javascript" async src="https://cdn.mathjax.org/mathjax/latest/MathJax.js?config=TeX-MML-AM_CHTML"> </script>
<script defer src="https://cdn.jsdelivr.net/npm/katex@0.11.1/dist/katex.min.js" integrity="sha384-y23I5Q6l+B6vatafAwxRu/0oK/79VlbSz7Q9aiSZUvyWYIYsd+qj+o24G5ZU2zJz" crossorigin="anonymous"></script>
<script defer src="https://cdn.jsdelivr.net/npm/katex@0.11.1/dist/contrib/auto-render.min.js" integrity="sha384-kWPLUVMOks5AQFrykwIup5lo0m3iMkkHrD0uJ4H5cjeGihAutqP0yW0J6dpFiVkI" crossorigin="anonymous"></script>
<script>
document.addEventListener("DOMContentLoaded", function() {
        renderMathInElement( document.body, {
delimiters: [
{left: "$$", right: "$$", display: true},
{left: "[%", right: "%]", display: true},
{left: "$", right: "$", display: false}
]}
);
        });
</script>


<script>
function wrap_img(fn) {
    if (document.attachEvent ? document.readyState === "complete" : document.readyState !== "loading") {
        var elements = document.querySelectorAll(".post img");
        Array.prototype.forEach.call(elements, function(el, i) {
                if (el.getAttribute("title")) {
                const caption = document.createElement('figcaption');
                var node = document.createTextNode(el.getAttribute("title"));
                caption.appendChild(node);
                const wrapper = document.createElement('figure');
                wrapper.className = 'image';
                el.parentNode.insertBefore(wrapper, el);
                el.parentNode.removeChild(el);
                wrapper.appendChild(el);
                wrapper.appendChild(caption);
                }
                });
    } else { document.addEventListener('DOMContentLoaded', fn); }
}
window.onload = wrap_img;
</script>











<link rel="stylesheet" href="/assets/css/style.css">
<script src="/assets/js/theme.js"></script>

</head>
<body><script src="https://cdnjs.cloudflare.com/ajax/libs/lunr.js/2.3.9/lunr.min.js"></script>
<script src="/assets/js/search.js"></script>

<header class="site-header">
  <div class="wrapper">
    <a class="site-title" rel="author" href="/">Just-in-Time learning</a>
    <nav class="site-nav">
      <input type="checkbox" id="nav-trigger" class="nav-trigger" />
      <label for="nav-trigger">
        <span class="menu-icon">
          <svg viewBox="0 0 18 15" width="18px" height="15px">
            <path
              d="M18,1.484c0,0.82-0.665,1.484-1.484,1.484H1.484C0.665,2.969,0,2.304,0,1.484l0,0C0,0.665,0.665,0,1.484,0 h15.032C17.335,0,18,0.665,18,1.484L18,1.484z M18,7.516C18,8.335,17.335,9,16.516,9H1.484C0.665,9,0,8.335,0,7.516l0,0 c0-0.82,0.665-1.484,1.484-1.484h15.032C17.335,6.031,18,6.696,18,7.516L18,7.516z M18,13.516C18,14.335,17.335,15,16.516,15H1.484 C0.665,15,0,14.335,0,13.516l0,0c0-0.82,0.665-1.484,1.484-1.484h15.032C17.335,12.031,18,12.696,18,13.516L18,13.516z" />
          </svg>
        </span>
      </label>

      <div class="trigger">
        <div class="search-container">
          <input type="text" id="search-input" placeholder="Search..." aria-label="Search posts" class="search-input">
          <div id="search-results" class="search-results"></div>
        </div>
        <a class="page-link" href="/aihub">AI Hub</a>
        <a class="page-link" href="/about">About</a>
        <button class="theme-toggle" onclick="toggleTheme()" id="theme-toggle">
  üåô Dark
</button>

<script>
function toggleTheme() {
    const body = document.querySelector('body');
    const button = document.getElementById('theme-toggle');
    const isDark = body.classList.toggle('dark-theme');
    
    button.innerHTML = isDark ? '‚òÄÔ∏è Light' : 'üåô Dark';
    localStorage.setItem('darkTheme', isDark);
}

document.addEventListener('DOMContentLoaded', function() {
    if (localStorage.getItem('darkTheme') === 'true') {
        document.querySelector('body').classList.add('dark-theme');
        document.getElementById('theme-toggle').innerHTML = '‚òÄÔ∏è Light';
    }
});
</script>

      </div>
    </nav>
  </div>
</header>
<main class="page-content" aria-label="Content">
      <div class="wrapper">
        <article class="post">
  <h1>üíä Lessons for Modern Drug Development from the Golden Age of Antibiotics</h1>
  
  <!-- Debug info -->
  <!-- <div style="color: red;"> -->
  <!--   TOC enabled: true -->
  <!--   Layout: post -->
  <!-- </div> -->
  
  
    <nav class="toc">
  <div class="toc-header">
    <h2>Contents</h2>
    <button class="toc-toggle" aria-label="Toggle table of contents">
      <svg class="toc-icon" viewBox="0 0 24 24" width="24" height="24">
        <path class="chevron-down" d="M6 9l6 6 6-6"></path>
      </svg>
    </button>
  </div>
  <div class="toc-content">
    <ul>
      
      
        
      
        
          
          <li class="toc-level-2">
            <a href="#introduction">Introduction</a>
            
            
            
          </li>
        
      
        
          
          <li class="toc-level-2">
            <a href="#when-urgency-met-innovation">When Urgency Met Innovation</a>
            
            
            
          </li>
        
      
        
          
          <li class="toc-level-2">
            <a href="#scientific-progress-and-market-failure">Scientific Progress and Market Failure</a>
            
            
            
          </li>
        
      
        
          
          <li class="toc-level-2">
            <a href="#integrating-economics-and-technology">Integrating Economics and Technology</a>
            
            
            
              <ul>
                
                  
                
                  
                    
                    <li class="toc-level-3">
                      <a href="#economic-solutions-to-market-failures">Economic Solutions to Market Failures</a>
                    </li>
                  
                
                  
                    
                    <li class="toc-level-3">
                      <a href="#leveraging-modern-technology">Leveraging Modern Technology</a>
                    </li>
                  
                
              </ul>
            
          </li>
        
      
        
          
          <li class="toc-level-2">
            <a href="#conclusion">Conclusion</a>
            
            
            
          </li>
        
      
    </ul>
  </div>
</nav>

  
  
  <!--more-->

<h2 id="introduction">Introduction</h2>

<p>In a thought-provoking analysis<sup id="fnref:1" role="doc-noteref"><a href="#fn:1" class="footnote" rel="footnote">1</a></sup>, Our World in Data reveals a striking paradox in medical progress: the most productive period in antibiotic development occurred in the two decades following World War II, with scientific capabilities far more limited than today. This ‚ÄúGolden Age of Antibiotics‚Äù (1940s-1960s) produced nearly two-thirds of the antibiotic drug classes we still rely on<sup id="fnref:2" role="doc-noteref"><a href="#fn:2" class="footnote" rel="footnote">2</a></sup>.<br />
Even more surprisingly, since 1970 -despite exponential advances in computing power and biotechnology- only eight new classes of antibiotics have been approved<sup id="fnref:2:1" role="doc-noteref"><a href="#fn:2" class="footnote" rel="footnote">2</a></sup>. This indicates a stark decline that threatens the foundation of modern medicine. Traditional screening methods now rediscover existing compounds most of the time rather than finding new ones<sup id="fnref:3" role="doc-noteref"><a href="#fn:3" class="footnote" rel="footnote">3</a></sup>.<br />
Modern tools like genome sequencing and systematic screening methods offer unprecedented capabilities. We‚Äôve only identified a small fraction of bacterial species, many of which could harbour new antibiotic compounds<sup id="fnref:2:2" role="doc-noteref"><a href="#fn:2" class="footnote" rel="footnote">2</a></sup>. Yet despite these capabilities, development has stagnated due to fundamental market failures and fragmented research efforts.<br />
This article examines this paradoxical inverse relationship between technological capability and antibiotic development: How did the Golden Age achieve such remarkable success with limited tools? Why has progress slowed as our capabilities have grown? Most importantly, what combinations of economic incentives and modern technology could spark a new era of antibiotic discovery?</p>

<h2 id="when-urgency-met-innovation">When Urgency Met Innovation</h2>

<p>The Golden Age of Antibiotics stands as medicine‚Äôs most productive period in antimicrobial discovery, yielding over 20 new antibiotic classes -more than double what we‚Äôve developed in the 50 years since<sup id="fnref:2:3" role="doc-noteref"><a href="#fn:2" class="footnote" rel="footnote">2</a></sup>. Three pivotal breakthroughs, coupled with unprecedented coordination, drove this remarkable success.<br />
The foundation was laid by Paul Ehrlich‚Äôs systematic approach to drug discovery. By methodically testing hundreds of compounds, he discovered <a href="https://en.wikipedia.org/wiki/Arsphenamine">salvarsan</a> in 1910 -the first synthetic antibiotic that effectively treated syphilis<sup id="fnref:2:4" role="doc-noteref"><a href="#fn:2" class="footnote" rel="footnote">2</a></sup>. A second milestone emerged when Alexander Fleming discovered penicillin in 1928. However, the real innovation came through coordinated wartime effort. With infections being the second-most common cause of hospital admissions in the US Army, the U.S. Office of Scientific Research and Development (OSRD) launched a global search for more productive penicillin strains, ultimately finding a high-yielding strain on a cantaloupe<sup id="fnref:4" role="doc-noteref"><a href="#fn:4" class="footnote" rel="footnote">4</a></sup>.<br />
The third breakthrough came from Selman Waksman‚Äôs insight into soil bacteria. His discovery that soil-dwelling <a href="https://en.wikipedia.org/wiki/Actinomycetales">actinomycetes</a> bacteria naturally produce antibiotics led to <a href="https://en.wikipedia.org/wiki/Streptomycin">streptomycin</a>‚Äôs development and opened an entirely new avenue for antibiotic discovery<sup id="fnref:5" role="doc-noteref"><a href="#fn:5" class="footnote" rel="footnote">5</a></sup>.<br />
What transformed these breakthroughs into a ‚Äúgolden age‚Äù was unprecedented coordination. The U.S. War Production Board orchestrated collaboration between government, academia, and industry -removing patent restrictions, sharing data, and streamlining clinical trials<sup id="fnref:6" role="doc-noteref"><a href="#fn:6" class="footnote" rel="footnote">6</a></sup>. The results were remarkable: some antibiotics, like <a href="https://en.wikipedia.org/wiki/Tetracycline_antibiotics">tetracyclines</a> and <a href="https://en.wikipedia.org/wiki/Macrolide">macrolides</a>, went from discovery to clinical use within the same year.</p>

<h2 id="scientific-progress-and-market-failure">Scientific Progress and Market Failure</h2>

<p>The contrast between the Golden Age and our current era reflects a fundamental misalignment between public health needs and market incentives<sup id="fnref:2:5" role="doc-noteref"><a href="#fn:2" class="footnote" rel="footnote">2</a></sup>. The market structure fundamentally disfavours antibiotics in two ways:</p>
<ol>
  <li>Revenue Structure: While chronic disease medications can generate billions in annual revenue over decades, new antibiotics typically generate only tens of millions annually<sup id="fnref:7" role="doc-noteref"><a href="#fn:7" class="footnote" rel="footnote">7</a></sup>, by comparison. This revenue gap has driven many large pharmaceutical companies away from antibiotic development<sup id="fnref:8" role="doc-noteref"><a href="#fn:8" class="footnote" rel="footnote">8</a></sup>.</li>
  <li>Conservation Requirements: New antibiotics must be reserved for severe drug-resistant infections, reaching less than 1% of hospitalised patients<sup id="fnref:7:1" role="doc-noteref"><a href="#fn:7" class="footnote" rel="footnote">7</a></sup>. This necessary conservation practice severely limits market potential.</li>
</ol>

<p>Meanwhile, our technological capabilities offer three particularly promising approaches:</p>
<ol>
  <li>Genome mining: a breakthrough technique that identifies hidden antibiotic genes in microbes that remain dormant under standard laboratory conditions. This computational approach has already yielded promising candidates like humimycins<sup id="fnref:9" role="doc-noteref"><a href="#fn:9" class="footnote" rel="footnote">9</a></sup>.</li>
  <li>Advanced bacterial exploration: research into extreme environments like deep oceans and deserts, where previously ‚Äúunculturable‚Äù bacteria might harbour entirely new antibiotic classes<sup id="fnref:3:1" role="doc-noteref"><a href="#fn:3" class="footnote" rel="footnote">3</a></sup>.</li>
  <li>Smart combination strategies: exploiting the observation that bacterial resistance to one antibiotic can increase vulnerability to others, opening new therapeutic possibilities<sup id="fnref:10" role="doc-noteref"><a href="#fn:10" class="footnote" rel="footnote">10</a></sup>.</li>
</ol>

<p>Yet these powerful tools remain underutilised due to insufficient investment and coordination. The challenge isn‚Äôt scientific capability -it‚Äôs the failure to create systems that effectively deploy these technologies within sustainable economic frameworks.</p>

<h2 id="integrating-economics-and-technology">Integrating Economics and Technology</h2>

<p>Drawing from evidence in antibiotic development research, several promising approaches could help overcome current market failures while leveraging modern technological capabilities<sup id="fnref:7:2" role="doc-noteref"><a href="#fn:7" class="footnote" rel="footnote">7</a></sup>.</p>

<h3 id="economic-solutions-to-market-failures">Economic Solutions to Market Failures</h3>

<ol>
  <li>Subscription Models: The UK has pioneered a system where healthcare systems pay annual fees for antibiotic access rather than per-volume pricing. This addresses both the revenue challenge and conservation requirements by providing stable income while supporting appropriate antibiotic use<sup id="fnref:7:3" role="doc-noteref"><a href="#fn:7" class="footnote" rel="footnote">7</a></sup>.</li>
  <li>Advance Market Commitments: These provide guaranteed payments to companies that successfully develop new antibiotics, similar to successful vaccine development programs. This directly addresses the revenue uncertainty that has driven companies away from antibiotic development<sup id="fnref:11" role="doc-noteref"><a href="#fn:11" class="footnote" rel="footnote">11</a></sup>.</li>
  <li>Collaborative Funding Initiatives: Organisations like CARB-X and GARDP help smaller companies navigate costly clinical trials, distributing development risks that large pharmaceutical companies are unwilling to bear<sup id="fnref:7:4" role="doc-noteref"><a href="#fn:7" class="footnote" rel="footnote">7</a></sup>.</li>
</ol>

<h3 id="leveraging-modern-technology">Leveraging Modern Technology</h3>

<p>To maximise the impact of these economic incentives, three technological approaches show particular promise:</p>
<ol>
  <li>Systematic Genome Mining: Using computational power to identify promising antibiotic-producing genes in bacterial genomes, revealing compounds that traditional screening would miss<sup id="fnref:9:1" role="doc-noteref"><a href="#fn:9" class="footnote" rel="footnote">9</a></sup>.</li>
  <li>Environmental Exploration: Research into extreme environments could unlock entirely new antibiotic classes, enabled by modern sequencing technologies<sup id="fnref:3:2" role="doc-noteref"><a href="#fn:3" class="footnote" rel="footnote">3</a></sup>.</li>
  <li>Smart Combination Strategies: Systematic exploration of how resistance to one antibiotic can increase vulnerability to others, offering new therapeutic possibilities<sup id="fnref:10:1" role="doc-noteref"><a href="#fn:10" class="footnote" rel="footnote">10</a></sup>.</li>
</ol>

<h2 id="conclusion">Conclusion</h2>

<p>The story of antibiotic development demonstrates that scientific capability alone cannot drive progress. The Golden Age succeeded through a powerful combination of systematic approaches, unprecedented collaboration, and removal of institutional barriers -even with limited technological tools<sup id="fnref:2:6" role="doc-noteref"><a href="#fn:2" class="footnote" rel="footnote">2</a></sup>.<br />
Today‚Äôs challenge is fundamentally different. We possess sophisticated tools -from genome mining to advanced screening methods- yet development has stalled. This paradox reveals that progress requires three key elements working in concert: economic incentives, institutional coordination, and technological application<sup id="fnref:7:5" role="doc-noteref"><a href="#fn:7" class="footnote" rel="footnote">7</a></sup>.<br />
The evidence-based solutions presented in the original Our World in Data article<sup id="fnref:1:1" role="doc-noteref"><a href="#fn:1" class="footnote" rel="footnote">1</a></sup> offer a path forward. Market reforms like subscription models and advance market commitments could help correct the fundamental economic misalignment in antibiotic development<sup id="fnref:8:1" role="doc-noteref"><a href="#fn:8" class="footnote" rel="footnote">8</a></sup>. Meanwhile, systematic application of computational tools, genomic analysis, and bacterial exploration could help unlock new classes of antibiotics that traditional methods miss<sup id="fnref:9:2" role="doc-noteref"><a href="#fn:9" class="footnote" rel="footnote">9</a></sup>.<br />
The urgency is clear. Antimicrobial resistance threatens to undermine many advances in modern medicine<sup id="fnref:12" role="doc-noteref"><a href="#fn:12" class="footnote" rel="footnote">12</a></sup>. However, by combining proven coordination approaches from the Golden Age with modern capabilities and sustainable economic frameworks, we can revitalise antibiotic development for the challenges ahead.</p>

<hr />
<div class="footnotes" role="doc-endnotes">
  <ol>
    <li id="fn:1" role="doc-endnote">
      <p>Our World in Data (2024). ‚ÄúWhat was the Golden Age of Antibiotics, and how can we spark a new one?‚Äù <a href="https://ourworldindata.org/golden-age-antibiotics">https://ourworldindata.org/golden-age-antibiotics</a>¬†<a href="#fnref:1" class="reversefootnote" role="doc-backlink">&#8617;</a>¬†<a href="#fnref:1:1" class="reversefootnote" role="doc-backlink">&#8617;<sup>2</sup></a></p>
    </li>
    <li id="fn:2" role="doc-endnote">
      <p>Hutchings, M. I., Truman, A. W., &amp; Wilkinson, B. (2019). Antibiotics: Past, present and future. Current Opinion in Microbiology, 51, 72‚Äì80. <a href="https://doi.org/10.1016/j.mib.2019.10.008">https://doi.org/10.1016/j.mib.2019.10.008</a>¬†<a href="#fnref:2" class="reversefootnote" role="doc-backlink">&#8617;</a>¬†<a href="#fnref:2:1" class="reversefootnote" role="doc-backlink">&#8617;<sup>2</sup></a>¬†<a href="#fnref:2:2" class="reversefootnote" role="doc-backlink">&#8617;<sup>3</sup></a>¬†<a href="#fnref:2:3" class="reversefootnote" role="doc-backlink">&#8617;<sup>4</sup></a>¬†<a href="#fnref:2:4" class="reversefootnote" role="doc-backlink">&#8617;<sup>5</sup></a>¬†<a href="#fnref:2:5" class="reversefootnote" role="doc-backlink">&#8617;<sup>6</sup></a>¬†<a href="#fnref:2:6" class="reversefootnote" role="doc-backlink">&#8617;<sup>7</sup></a></p>
    </li>
    <li id="fn:3" role="doc-endnote">
      <p>Kolter, R., &amp; Van Wezel, G. P. (2016). Goodbye to brute force in antibiotic discovery? Nature Microbiology, 1(2), 15020. <a href="https://doi.org/10.1038/nmicrobiol.2015.20">https://doi.org/10.1038/nmicrobiol.2015.20</a>¬†<a href="#fnref:3" class="reversefootnote" role="doc-backlink">&#8617;</a>¬†<a href="#fnref:3:1" class="reversefootnote" role="doc-backlink">&#8617;<sup>2</sup></a>¬†<a href="#fnref:3:2" class="reversefootnote" role="doc-backlink">&#8617;<sup>3</sup></a></p>
    </li>
    <li id="fn:4" role="doc-endnote">
      <p>Gaynes, R. (2017). The Discovery of Penicillin -New Insights After More Than 75 Years of Clinical Use. Emerging Infectious Diseases, 23(5), 849‚Äì853. <a href="https://doi.org/10.3201/eid2305.161556">https://doi.org/10.3201/eid2305.161556</a>¬†<a href="#fnref:4" class="reversefootnote" role="doc-backlink">&#8617;</a></p>
    </li>
    <li id="fn:5" role="doc-endnote">
      <p>Waksman, S. A., &amp; Schatz, A. (1945). Streptomycin‚ÄìOrigin, Nature, and Properties. Journal of the American Pharmaceutical Association, 34(11), 273‚Äì291. <a href="https://doi.org/10.1002/jps.3030341102">https://doi.org/10.1002/jps.3030341102</a>¬†<a href="#fnref:5" class="reversefootnote" role="doc-backlink">&#8617;</a></p>
    </li>
    <li id="fn:6" role="doc-endnote">
      <p>Sampat, B. N. (2023). Second World War and the Direction of Medical Innovation. SSRN Electronic Journal. <a href="https://doi.org/10.2139/ssrn.4422261">https://doi.org/10.2139/ssrn.4422261</a>¬†<a href="#fnref:6" class="reversefootnote" role="doc-backlink">&#8617;</a></p>
    </li>
    <li id="fn:7" role="doc-endnote">
      <p>√Ördal, C., et al. (2020). Antibiotic development -economic, regulatory and societal challenges. Nature Reviews Microbiology, 18(5), 267-274. <a href="https://doi.org/10.1038/s41579-019-0293-3">https://doi.org/10.1038/s41579-019-0293-3</a>¬†<a href="#fnref:7" class="reversefootnote" role="doc-backlink">&#8617;</a>¬†<a href="#fnref:7:1" class="reversefootnote" role="doc-backlink">&#8617;<sup>2</sup></a>¬†<a href="#fnref:7:2" class="reversefootnote" role="doc-backlink">&#8617;<sup>3</sup></a>¬†<a href="#fnref:7:3" class="reversefootnote" role="doc-backlink">&#8617;<sup>4</sup></a>¬†<a href="#fnref:7:4" class="reversefootnote" role="doc-backlink">&#8617;<sup>5</sup></a>¬†<a href="#fnref:7:5" class="reversefootnote" role="doc-backlink">&#8617;<sup>6</sup></a></p>
    </li>
    <li id="fn:8" role="doc-endnote">
      <p>Renwick, M. J., Brogan, D. M., &amp; Mossialos, E. (2016). A systematic review and critical assessment of incentive strategies for discovery and development of novel antibiotics. The Journal of Antibiotics, 69(2), 73-88. <a href="https://doi.org/10.1038/ja.2015.98">https://doi.org/10.1038/ja.2015.98</a>¬†<a href="#fnref:8" class="reversefootnote" role="doc-backlink">&#8617;</a>¬†<a href="#fnref:8:1" class="reversefootnote" role="doc-backlink">&#8617;<sup>2</sup></a></p>
    </li>
    <li id="fn:9" role="doc-endnote">
      <p>Chu, J., et al. (2016). Discovery of MRSA active antibiotics using primary sequence from the human microbiome. Nature Chemical Biology, 12(12), 1004-1006. <a href="https://doi.org/10.1038/nchembio.2207">https://doi.org/10.1038/nchembio.2207</a>¬†<a href="#fnref:9" class="reversefootnote" role="doc-backlink">&#8617;</a>¬†<a href="#fnref:9:1" class="reversefootnote" role="doc-backlink">&#8617;<sup>2</sup></a>¬†<a href="#fnref:9:2" class="reversefootnote" role="doc-backlink">&#8617;<sup>3</sup></a></p>
    </li>
    <li id="fn:10" role="doc-endnote">
      <p>Baym, M., Stone, L. K., &amp; Kishony, R. (2016). Multidrug evolutionary strategies to reverse antibiotic resistance. Science, 351(6268), aad3292. <a href="https://doi.org/10.1126/science.aad3292">https://doi.org/10.1126/science.aad3292</a>¬†<a href="#fnref:10" class="reversefootnote" role="doc-backlink">&#8617;</a>¬†<a href="#fnref:10:1" class="reversefootnote" role="doc-backlink">&#8617;<sup>2</sup></a></p>
    </li>
    <li id="fn:11" role="doc-endnote">
      <p>Kremer, M., Levin, J., &amp; Snyder, C. M. (2020). Advance Market Commitments: Insights from Theory and Experience. AEA Papers and Proceedings, 110, 269-273. <a href="https://www.aeaweb.org/articles?id=10.1257/pandp.20201017">https://www.aeaweb.org/articles?id=10.1257/pandp.20201017</a>¬†<a href="#fnref:11" class="reversefootnote" role="doc-backlink">&#8617;</a></p>
    </li>
    <li id="fn:12" role="doc-endnote">
      <p>World Health Organization (2024). Antimicrobial Resistance Fact Sheet. <a href="https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance">https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance</a>¬†<a href="#fnref:12" class="reversefootnote" role="doc-backlink">&#8617;</a></p>
    </li>
  </ol>
</div>

</article>

<!-- Theme toggle -->
<script>
// Initialize theme from localStorage
if (localStorage.getItem('darkTheme') === 'true') {
    document.body.classList.add('dark-theme');
}
</script>

<!-- Collapsible TOC -->
<script>
document.addEventListener('DOMContentLoaded', function() {
  const tocHeader = document.querySelector('.toc-header');
  const toc = document.querySelector('.toc');
  
  if (tocHeader && toc) {
    tocHeader.addEventListener('click', function() {
      toc.classList.toggle('collapsed');
      
      // Optional: Save state to localStorage
      localStorage.setItem('tocCollapsed', toc.classList.contains('collapsed'));
    });
    
    // Optional: Restore state from localStorage
    const isCollapsed = localStorage.getItem('tocCollapsed') === 'true';
    if (isCollapsed) {
      toc.classList.add('collapsed');
    }
  }
});
</script>

<div class="post-tags">
  Tags: 
  
    <a href="/">iterative-refinement</a>, 
  
    <a href="/">evolution</a>, 
  
    <a href="/">data-science</a>, 
  
    <a href="/">evaluation</a>, 
  
    <a href="/">decision-making</a>, 
  
    <a href="/">best-practices</a>, 
  
    <a href="/">modelling-mindsets</a>, 
  
    <a href="/">production</a>
  
</div>


      </div>
    </main><footer class="site-footer h-card">
  <data class="u-url" href="/"></data>

  <div class="wrapper">

    <h2 class="footer-heading">Just-in-Time learning</h2>

    <div class="footer-col-wrapper">
      <div class="footer-col footer-col-1">
        <ul class="contact-list">
          <li class="p-name">Just-in-Time learning</li></ul>
      </div>

      <div class="footer-col footer-col-2"><ul class="social-media-list">
  <li><a href="https://github.com/ai-mindset"><svg class="svg-icon"><use xlink:href="/assets/minima-social-icons.svg#github"></use></svg> <span class="username">ai-mindset</span></a></li></ul>
</div>

      <div class="footer-col footer-col-3">
        <p>Inquisitive. Learning. Sharing. Simplicity = Reliability</p>
      </div>
    </div>

  </div>

</footer>
</body>

</html>
